Autolus Therapeutics (AUTL)

• Market cap: $413M
• 1 day: 2.65%
• 5 days: -4.32%
• 1 month: -4.91%
• 3 months: -35.42%
• 6 months: 9.93%
• Year to date: -41.06%
• 1 year: -54.01%
• 5 years: -86.26%
• 10 years: -93.8%
• Sector: Healthcare
• Industry: Biotechnology

About: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Employees: 647